CAS 41575-94-4
:Carboplatino
Descripción:
Carboplatino es un fármaco de quimioterapia a base de platino que se utiliza principalmente en el tratamiento de varios tipos de cáncer, incluyendo cáncer de ovario, cáncer testicular y cáncer de vejiga. Es un compuesto de platino de segunda generación, estructuralmente relacionado con el cisplatino pero con un ligando diferente, lo que mejora su perfil terapéutico y reduce ciertos efectos secundarios. Carboplatino se caracteriza por su capacidad para formar enlaces cruzados en el ADN, lo que lleva a la inhibición de la replicación del ADN y, en última instancia, desencadena la apoptosis en las células cancerosas. Su solubilidad en agua permite la administración intravenosa, y generalmente se administra en ciclos para maximizar la eficacia mientras se minimiza la toxicidad. Los efectos secundarios comunes incluyen mielosupresión, náuseas, vómitos y toxicidad renal, aunque estos son generalmente menos severos en comparación con el cisplatino. La efectividad del fármaco a menudo se ve influenciada por la presencia de biomarcadores específicos en los tumores, y se utiliza con frecuencia en combinación con otros agentes quimioterapéuticos para mejorar los resultados del tratamiento. El mecanismo de acción de Carboplatino y su perfil de efectos secundarios relativamente favorable lo convierten en una opción valiosa en las terapias oncológicas.
Fórmula:C6H12N2O4Pt
InChI:InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6;;;/h1-3H2,(H,7,8)(H,9,10);2*1H2;/q;2*-1;+4/p-2/rC6H10N2O4Pt/c7-13(8)11-4(9)6(2-1-3-6)5(10)12-13/h1-3,7-8H2
Clave InChI:InChIKey=OLESAACUTLOWQZ-UHFFFAOYSA-L
SMILES:O=C1C2(C(=O)[O-][Pt+2]([NH3])([NH3])[O-]1)CCC2
Sinónimos:- (SP-4-2)-Diammine[1,1-cyclobutanedicarboxylato(2-)-κO,κO′′]platinum
- 1,1-Cyclobutanedicarboxylic acid, platinum complex
- Carbomedac
- Carboplatin
- Carboplatinum
- Carbosin
- Cbdca
- Cycloplatin
- Diammin[cyclobutan-1,1-dicarboxylato(2-)-O,O']platin
- Jm 8
- Nsc 201345
- Nsc 241240
- Paraplat
- Paraplatin
- Platinum, diammine[1,1-cyclobutanedicarboxylato(2-)-κO,κO'']-, (SP-4-2)-
- Platinum, diammine[1,1-cyclobutanedicarboxylato(2-)]-, (SP-4-2)-
- Ribocarbo L
- cis-Diammine(1,1-cyclobutanedicarboxylato)platinum
- cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)
- cis-Diammine(cyclobutane-1,1-dicarboxylate-O,O′)platinum(II)
- cis-Diammine[1,1-cyclobutanedicarboxylato(2-)]platinum
- cis-Diammineplatinum 1,1-cyclobutanedicarboxylate
- diamino[ciclobutano-1,1-dicarboxilato(2-)-O,O']platino
- diammine[cyclobutane-1,1-dicarboxylato(2-)-O,O']platine
- diammine[cyclobutane-1,1-dicarboxylato(2-)-O,O']platinum
- diamino[cyclobutane-1,1-dicarboxylato(2-)-kappa~2~O~1~,O~1~]platinum
- 1,1-Cyclobutanedicarboxylate diamine platinum(II)
- cis-(1,1-Cyclobutanedicarboxylato)diamineplatinum(II)
- 1,1-Cyclobutanedicarboxylatodiammineplatinum
- cyclobutane-1,1-dicarboxylic acid - platinum ammoniate (1:1:2)
- Platinum, diammine[1,1-cyclobutanedi(carboxylato-κO)(2-)]-, (SP-4-2)-
- platinum(2+) azanide cyclobutane-1,1-dicarboxylic acid (1:2:1)
- 6,8-dioxa-7$l^{2}-platinaspiro[3.5]nonane-5,9-dione
- ammonia
- 1,1-cyclobutanedicarboxylic acid, platinum(2+) salt (1:1), diammoniate
- diammine(1,1-cyclobutanedicarboxylato)-platinum(I
- Platinum, diamine(1,1-cyclobutanedicarboxylato(2-)-O,O')-,(SP-4-2)-
- cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II)
- 1-cyclobutanedicarboxylato)diammine-(cis-platinum(ii
- 1-cyclobutanedicarboxylato(2-)-o,o’)-diammine((sp-4-2)-platinu
- Carboplatin usp25
- (SP-4-2)-Diamimine[1,1-cyclobutanedi(carboxylato-kO)(2-)]platinum
- JM-8:NSC-241240
- DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM(II)
- CIS-DIAMMINE[1,1-CYCLOBUTANE-DICARBOYLATO]PLATINUM
- CIS-DIAMMINE-[1,1-CYCLOBUTANE-DICARBOXYLATO]PLATIN
- PARAPLATIN (CARBOPLATIN)
- (SP-4-2)-Diamrnine[1,1-cyclobutanedicarboxylato(2-)-O,O’]platinuln
- 1,1-CYCLOBUTANEDICARBOXYLATODIAMMINEPLATINUM(II) CARBOPLATIN
- CIS-DIAMMINE[1,1-CYCLOBUTANE-DICARBOXYLATO] PLATINUM
- CarboplatinUsp24
- diammine-1,1-cyclobutanedicarboxylateplatinumi
- Ercar
- 1,1-cyclobutanedicarboxylatediammineplatinum(ii)
- CarboplatinUsp28
- Carboplatin (100 mg)
- CARBONPLATIN
- 1,1-CYCLOBUTANEDICARBOXYLATODIAMMINEPLATINUM(II)
- CARBOPLATIN (DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM(II))
- 1,1-Cyclobutanedicarboxylatodiammineplatinum(II),99%CARBOPLATIN
- 1,1-cyclobutanedicarboxylate diammine platinum
- SP-4-2)-Diammine[1,1-cyclobutanedicar-boxylato-(2-)O,O’]platinum
- CIS-DIAMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM
- cis-(1,1-cyclobutanedicarboxylato)diammineplatinum
- cis-(1,1-cyclobutanedicarboxylato)diammineplatinum(ii)
- diammine(1,1-cyclobutanedicarboxylato)platinum
- Platinum, diammine1,1-cyclobutanedi(carboxylato-.kappa.O)(2-)-, (SP-4-2)-
- 1,1-CYCLOBUTANEDICARBOXYLATODIAMMINEPLATINUM(II), 99% USP CARBOPLATIN
- Carboplatin/cis-DiaMMine[1,1 cyclobutane dicarboxylato] platinuM
- Carboplatin99%
- Ver más sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 16 productos.
Carboplatin
CAS:Fórmula:C6H12N2O4PtPureza:>98.0%(HPLC)Forma y color:White to Light yellow powder to crystalPeso molecular:371.26Carboplatin
CAS:<p>Carboplatin is primarily used as an antitumor agent.Carboplatin is widely utilized as a chemotherapy drug to treat various types of cancer. It belongs to the group of platinum-based antineoplastic agents to interfere in DNA (deoxyribonucleic acid) repair. It is applied in combination other medicatio</p>Fórmula:C6H12N2O4PtForma y color:White to off-white, PowderPeso molecular:371.26Carboplatin
CAS:CarboplatinFórmula:C6H12N2O4PtPureza:99.8%Forma y color:White To Off-WhitePeso molecular:371.0445Carboplatin
CAS:Inorganic or organic compounds of precious metals, whether or not chemically defined; amalgrams of precious metals, nesoiFórmula:C6H12N2O4PtForma y color:White PowderPeso molecular:371.0445Carboplatin
CAS:<p>Carboplatin (JM-8) is a cisplatin derivative, a DNA synthesis inhibitor.</p>Fórmula:C6H12N2O4PtPureza:98% - 99.72%Forma y color:White Crystalline PowderPeso molecular:371.25Carboplatin
CAS:Fórmula:C6H12N2O4PtPureza:≥ 98.0% (anhydrous basis)Forma y color:White or almost white crystalline powderPeso molecular:371.25Carboplatin
CAS:<p>Applications Analog of Cisplatin with reduced nephrotoxicity. Antineoplastic.<br>References Harland, S.J., et al.: Cancer Res., 44, 1693 (1984), Smith, I.E., et al.: Cancer Treat. Rep., 69, 43 (1985), Lygidakis, N.J., et al.: Interferon Cytokine Res., 15, 467 (1995),<br></p>Fórmula:C6H12N2O4PtForma y color:White To Off-WhitePeso molecular:371.25Carboplatin-d4
CAS:Producto controlado<p>Stability Hygroscopic<br>Applications Analog of Cisplatin with reduced nephrotoxicity. Antineoplastic.<br>References Harland, S.J., et al.: Cancer Res., 44, 1693 (1984), Smith, I.E., et al.: Cancer Treat. Rep., 69, 43 (1985), Lygidakis, N.J., et al.: Interferon Cytokine Res., 15, 467 (1995),<br></p>Fórmula:C6H8D4N2O4PtForma y color:White To Off-WhitePeso molecular:375.27Carboplatin - Bio-X ™
CAS:<p>Carboplatin is an antineoplastic alkylating agent that is used in the treatment of ovarian cancer. This drug attaches alkyl groups to nucleotides leading to the formation of monoadducts. Carboplatin’s main mechanism of action is preventing DNA strands from separating for synthesis and transcription.</p>Fórmula:C6H12N2O4PtPureza:Min. 95%Forma y color:PowderPeso molecular:371.25 g/molCarboplatin
CAS:<p>Platinum-based anti-cancer agent</p>Fórmula:C6H12N2O4PtPureza:Min. 95%Forma y color:PowderPeso molecular:371.25 g/mol1,1-Cyclobutanedicarboxylatodiammineplatinum
CAS:Fórmula:C6H12N2O4PtPureza:97.0%Peso molecular:371.256Platinum, diammine[1,1-cyclobutanedi(carboxylato-kO)(2-)]-, (SP-4-2)-
CAS:Fórmula:C6H10N2O4PtPureza:98%Forma y color:SolidPeso molecular:369.2326Ref: IN-DA00I84B
Producto descatalogado













